Supplemental Figure 1 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute My... Yazar: Amir T. Fathi (15313195)

Diğer Yazarlar: “…Haesook T. Kim (15313198)…”

Supplemental Figure 2 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute My... Yazar: Amir T. Fathi (15313195)

Diğer Yazarlar: “…Haesook T. Kim (15313198)…”